• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有抗氧化功能的新型选择性丁酰胆碱酯酶抑制剂作为阿尔茨海默病的潜在双峰疗法

Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer's Disease.

作者信息

Jones Mike, Wang Jun, Harmon Shona, Kling Beata, Heilmann Jörg, Gilmer John F

机构信息

School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland.

Institute of Pharmacy, University of Regensburg, 93053 Regensburg, Germany.

出版信息

Molecules. 2016 Apr 1;21(4):440. doi: 10.3390/molecules21040440.

DOI:10.3390/molecules21040440
PMID:27534722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6273432/
Abstract

Isosorbide-2-carbamates-5-aryl esters are highly potent and very selective butyrylcholinesterase inhibitors. The objective of the present work was to address the hypothesis that the isosorbide-aryl-5-ester group could be replaced with an antioxidant functionality while maintaining inhibitor effects and selectivity. We successfully incorporated ferulic acid or lipoic acid groups producing potent selective inhibitors of butyrylcholinesterase (BuChE). The hybrid compounds were non-toxic to the murine hippocampal cell line HT-22 and lipoate esters were neuroprotective at 10 and 25 µM when the cells were challenged with glutamate (5 mM) in a similar manner to the positive control quercetin. The benzyl carbamate 7a was a potent inhibitor of BuChE (IC50 150 nM) and it was effective in reducing glutamate toxicity to neuronal cells at >5 µM. Representative compounds exhibited an antioxidant effect in the oxygen radical absorbance capacity assay as the lipoate 7d was not active, whereas the ferulate 8a showed a weak, but significant, activity with 0.635 ± 0.020 Trolox Equivalent.

摘要

异山梨醇 -2 -氨基甲酸酯 -5 -芳基酯是高效且极具选择性的丁酰胆碱酯酶抑制剂。本研究的目的是验证以下假设:异山梨醇 -芳基 -5 -酯基团可被抗氧化官能团取代,同时保持抑制剂的效果和选择性。我们成功引入了阿魏酸或硫辛酸基团,从而制备出了高效的丁酰胆碱酯酶(BuChE)选择性抑制剂。这些杂合化合物对小鼠海马细胞系HT -22无毒,并且当细胞以与阳性对照槲皮素类似的方式受到谷氨酸(5 mM)刺激时,硫辛酸酯在10和25 μM浓度下具有神经保护作用。苄基氨基甲酸酯7a是BuChE的强效抑制剂(IC50为150 nM),并且在浓度大于5 μM时能有效降低谷氨酸对神经元细胞的毒性。代表性化合物在氧自由基吸收能力测定中表现出抗氧化作用,因为硫辛酸酯7d无活性,而阿魏酸酯8a表现出较弱但显著的活性,其Trolox当量为0.635±0.020。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/6273432/bb046722e19c/molecules-21-00440-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/6273432/feba1a23b766/molecules-21-00440-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/6273432/bfa9dab495b1/molecules-21-00440-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/6273432/bb046722e19c/molecules-21-00440-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/6273432/feba1a23b766/molecules-21-00440-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/6273432/bfa9dab495b1/molecules-21-00440-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/6273432/bb046722e19c/molecules-21-00440-g002.jpg

相似文献

1
Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer's Disease.具有抗氧化功能的新型选择性丁酰胆碱酯酶抑制剂作为阿尔茨海默病的潜在双峰疗法
Molecules. 2016 Apr 1;21(4):440. doi: 10.3390/molecules21040440.
2
Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors.异山梨醇-2-氨基甲酸酯类:强效且选择性的丁酰胆碱酯酶抑制剂。
J Med Chem. 2008 Oct 23;51(20):6400-9. doi: 10.1021/jm800564y. Epub 2008 Sep 26.
3
Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine.从天然生物碱吴茱萸碱衍生出的一种具有神经保护作用的选择性丁酰胆碱酯酶抑制剂的鉴定。
Eur J Med Chem. 2014 Jun 23;81:15-21. doi: 10.1016/j.ejmech.2014.05.002. Epub 2014 May 4.
4
Novel carbamate derivatives as selective butyrylcholinesterase inhibitors.新型氨基甲酸酯衍生物作为选择性丁酰胆碱酯酶抑制剂。
Bioorg Chem. 2018 Aug;78:29-38. doi: 10.1016/j.bioorg.2018.03.003. Epub 2018 Mar 3.
5
Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease.芳基脲苯并呋喃噻唑杂合体作为阿尔茨海默病多任务药物的潜力。
Eur J Med Chem. 2015 Sep 18;102:80-92. doi: 10.1016/j.ejmech.2015.07.005. Epub 2015 Jul 10.
6
Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode.通过对其抑制模式的合理研究,发现高选择性和纳摩尔级的基于氨基甲酸酯的丁酰胆碱酯酶抑制剂。
J Med Chem. 2016 Mar 10;59(5):2067-82. doi: 10.1021/acs.jmedchem.5b01674. Epub 2016 Feb 17.
7
Synthesis and structure activity relationships (SAR) of a new class of potent and selective butyrylcholinesterase inhibitors.
Chem Biol Interact. 2005 Dec 15;157-158:380-1. doi: 10.1016/j.cbi.2005.10.063.
8
Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.发现新型吡唑并嘧啶酮衍生物作为磷酸二酯酶 9A 抑制剂,能够抑制丁酰胆碱酯酶,用于治疗阿尔茨海默病。
ACS Chem Neurosci. 2017 Nov 15;8(11):2522-2534. doi: 10.1021/acschemneuro.7b00268. Epub 2017 Aug 23.
9
Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.带有氨基甲酸酯部分的环状酰基胍能够对乙酰胆碱酯酶或丁酰胆碱酯酶产生强效且可控的抑制作用。
Bioorg Med Chem. 2014 Sep 1;22(17):5020-34. doi: 10.1016/j.bmc.2014.06.010. Epub 2014 Jun 26.
10
Design, synthesis, and biological evaluation of scutellarein carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.作为治疗阿尔茨海默病潜在多功能药物的黄芩素氨基甲酸酯衍生物的设计、合成及生物学评价
Chem Biol Drug Des. 2015 Nov;86(5):1168-77. doi: 10.1111/cbdd.12580. Epub 2015 May 20.

引用本文的文献

1
Incorporation of an Isohexide Subunit Improves the Drug-like Properties of Bioactive Compounds.异山梨醇亚基的引入改善了生物活性化合物的类药物性质。
ACS Med Chem Lett. 2023 Jan 20;14(2):176-182. doi: 10.1021/acsmedchemlett.2c00476. eCollection 2023 Feb 9.
2
Beyond Antioxidant Effects: Nature-Based Templates Unveil New Strategies for Neurodegenerative Diseases.超越抗氧化作用:基于天然的模板揭示神经退行性疾病的新策略。
Antioxidants (Basel). 2021 Feb 28;10(3):367. doi: 10.3390/antiox10030367.
3
Design, synthesis, in vivo and in vitro studies of 1,2,3,4-tetrahydro-9H-carbazole derivatives, highly selective and potent butyrylcholinesterase inhibitors.

本文引用的文献

1
Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives.应对阿尔茨海默病的多靶点策略:基于香豆素的衍生物的设计、合成、生物学评价及计算研究
ChemMedChem. 2016 Jun 20;11(12):1296-308. doi: 10.1002/cmdc.201500392. Epub 2015 Oct 28.
2
Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse.丁酰胆碱酯酶基因敲除小鼠的学习能力及对淀粉样蛋白毒性的易感性
Behav Brain Res. 2016 Jan 1;296:351-360. doi: 10.1016/j.bbr.2015.08.026. Epub 2015 Aug 22.
3
The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.
设计、合成、体内和体外研究 1,2,3,4-四氢咔唑衍生物,高选择性和高效的丁酰胆碱酯酶抑制剂。
Mol Divers. 2020 Feb;24(1):211-223. doi: 10.1007/s11030-019-09943-6. Epub 2019 Mar 29.
4
Cholinesterases and the fine line between poison and remedy.胆碱酯酶与毒与药之间的微妙界限。
Biochem Pharmacol. 2018 Jul;153:205-216. doi: 10.1016/j.bcp.2018.01.044. Epub 2018 Jan 31.
5
Special Issue: "Molecules against Alzheimer".特刊:“对抗阿尔茨海默病的分子”。
Molecules. 2016 Dec 16;21(12):1736. doi: 10.3390/molecules21121736.
胆碱酯酶抑制剂在阿尔茨海默病各阶段的应用。
Drugs Aging. 2015 Jul;32(7):537-47. doi: 10.1007/s40266-015-0273-x.
4
Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybrids.新型他克林嫁接的乌吉加合物作为多效抗阿尔茨海默病药物:他克林 - 阿魏酸杂化物的合成新进展
ChemMedChem. 2015 Mar;10(3):523-39. doi: 10.1002/cmdc.201402409. Epub 2014 Dec 23.
5
Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.一种新型纳摩尔级选择性丁酰胆碱酯酶抑制剂的发现、生物学评价及晶体结构
J Med Chem. 2014 Oct 9;57(19):8167-79. doi: 10.1021/jm501195e. Epub 2014 Sep 29.
6
Physiological effect and therapeutic application of alpha lipoic acid.α-硫辛酸的生理作用及治疗应用
Curr Med Chem. 2014;21(32):3636-45. doi: 10.2174/0929867321666140706141806.
7
Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine.从天然生物碱吴茱萸碱衍生出的一种具有神经保护作用的选择性丁酰胆碱酯酶抑制剂的鉴定。
Eur J Med Chem. 2014 Jun 23;81:15-21. doi: 10.1016/j.ejmech.2014.05.002. Epub 2014 May 4.
8
Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.多奈哌齐、加兰他敏、卡巴拉汀和美金刚治疗阿尔茨海默病的疗效与安全性:一项系统评价和荟萃分析。
J Alzheimers Dis. 2014;41(2):615-31. doi: 10.3233/JAD-132690.
9
Flavonoids, flavonoid metabolites, and phenolic acids inhibit oxidative stress in the neuronal cell line HT-22 monitored by ECIS and MTT assay: a comparative study.类黄酮、类黄酮代谢物和酚酸通过 ECIS 和 MTT 测定抑制神经元细胞系 HT-22 的氧化应激:一项比较研究。
J Nat Prod. 2014 Mar 28;77(3):446-54. doi: 10.1021/np400518k. Epub 2013 Nov 18.
10
Ferulic acid is a nutraceutical β-secretase modulator that improves behavioral impairment and alzheimer-like pathology in transgenic mice.阿魏酸是一种具有营养保健功能的β-分泌酶调节剂,可改善转基因小鼠的行为障碍和阿尔茨海默病样病理。
PLoS One. 2013;8(2):e55774. doi: 10.1371/journal.pone.0055774. Epub 2013 Feb 8.